Keynote Speakers
Paul Workman Chief Executive and President, Institute of Cancer Research, London | 
Stefan Knapp Professor, Goethe Institut Frankfurt | 
Michelle Arkin Director of the Small Molecule Discovery Center, University of California San Francisco | 
Ludovic Vallier Professor, University Of Cambridge | 
Sir Alan Fersht Professor, MRC Laboratory of Molecular Biology | 
Sally Ward Professor, Texas A&M Health Science Center |
|

Christine Mummery Professor and Chair of Developmental Biology, Leiden University Medical Centre | 
Danica Fujimori Principal Investigator, University of California, San Francisco | 
James Audia Chief Scientific Officer, Constellation Pharmaceuticals | 
Dafydd Owen Associate Research Fellow, Pfizer Ltd |
View all
Overview4 Conferences, 1 Venue
SELECTBIO is pleased to announce that Advances in Drug Discovery will be taking place at the Wellcome Genome Campus, Hinxton, Cambridge on 6 - 7 March, 2017. With over 300 attendees expected, this multi-track event builds on the success of our Cambridge Workshop Series and will feature four tracks: As a multi-track event, delegates will have unrestricted access to all conference tracks and networking opportunities. If you are looking to hear from the experts; learn new skills; discover new ideas, trends & concepts; Advances in Drug Discovery 2017 is not to be missed. Conference DinnerWith a gala dinner included on the first evening, informal networking will go on into the night. Need to convince your boss?Check out our 11 Reasons Not to Miss Advances in Drug Discovery 2017. SELECTBIO is offering a limited number of student bursaries at this event. Find out more
Information and local registration facilities for this conference is also available in:
Japanese
|
Korean
|
Chinese(Simplified)
|
Chinese(Traditional)
Agenda and Information for:
|
|
|
Corporate Sponsors
|
Media Sponsors
|
|
Networking
|
|
|
|
|
|